[Translation] An open, randomized, single-dose, three-period partially repeated crossover study designed to evaluate the bioequivalence of minodronic acid tablets in healthy volunteers under fasting conditions
本试验采用开放、随机、单次给药、三周期部分重复交叉试验设计,以原研药Astellas Pharma Inc.公司生产的米诺膦酸片(商品名:Bonoteo®)为参比制剂,评价空腹状态下江苏天士力帝益药业有限公司生产的受试制剂米诺膦酸片在中国健康志愿者体内药代动力学和生物等效性。为注册提供临床依据。
[Translation] This trial adopts an open, randomized, single-dose, three-period partially repeated crossover design, using minodronic acid tablets (trade name: Bonoteo®) produced by the original drug Astellas Pharma Inc. as the reference preparation to evaluate the pharmacokinetics and bioequivalence of the test preparation minodronic acid tablets produced by Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. in healthy Chinese volunteers under fasting conditions, providing clinical basis for registration.